High Dose Rate Yttrium (90Y) Episcleral Plaque Brachytherapy for Iris and Iridociliary Melanoma
To describe a pilot study on the use of single-session, high-dose-rate, FDA-cleared, yttrium-90 (90Y) plaque brachytherapy for iris and iridociliary melanoma.